Existing investors Delphi Ventures, Alloy Ventures, Johnson & Johnson Development Corporation, Three Arch Partners, Thomas J.
Tibion Corporation, a leader in the development of active orthotic devices based on bionic technologies, today announced that medical device luminary Thomas J.
Novare's products were designed by prominent cardiac surgeon and inventor, Thomas J.
The Solera reduces treatment time, is easy to use and is a minimally invasive procedure," said Thomas J.
Existing investors including Domain Associates, Thomas J.
Nasdaq: CRLN) today announced the election of Thomas J.
It is noteworthy that there has been no loss of primary patency between the 6 and 9 month data from this clinical trial," commented Thomas J.
There are several attributes of the Vascular Architects aSpire Covered Stent that make it an excellent vehicle for intraluminal delivery of drugs," stated Thomas J.
Bacchus Vascular was founded in 1999 by renowned inventor and physician Thomas J.
Raytel Medical Corporation (Nasdaq:RTEL) announced today that Thomas J.
This early data is very encouraging considering that the average length of the lesions treated in the trial is beyond what most physicians will treat today without open surgery," said Thomas J.
Vascular Architects was founded in 1997 by surgeon, inventor and entrepreneur Thomas J.